Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval
Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval
aliu
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *